New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
W. Ray Kim, MD
Hepatologist, Gastroenterologist
Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center
Bio:
Chronic liver disease is one of the most common causes of premature death in Americans. My career goal is to improve the outcome of individuals with chronic liver disease by identifying the optimal means for diagnosis, monitoring, treatment and prevention. The path I have chosen to achieve this goal is through engagement in clinical epidemiology and patient-oriented, effectiveness research.
Since the development of the MELD score which recognizes the importance of renal function in the prognosis of patients with end stage liver disease, one of the areas that we have had intense interest has been acute and chronic renal injury in patients undergoing liver transplantation. Liver transplantation represents a unique opportunity for research, because of the potential for reversal of the renal injury as well as access to biological materials.
Since the development of the MELD score which recognizes the importance of renal function in the prognosis of patients with end stage liver disease, one of the areas that we have had intense interest has been acute and chronic renal injury in patients undergoing liver transplantation. Liver transplantation represents a unique opportunity for research, because of the potential for reversal of the renal injury as well as access to biological materials.
- 900 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-498-7878
- 900 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-736-5555
- 900 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-498-7999
Practice Areas
- Alcohol Hepatitis
- Alcohol-Induced Liver Disease
- Autoimmune Hepatitis
- Chronic Liver Disease
- Drug Induced Hepatitis
- Fatty Liver Disease
- Gallstones
- Hemochromatosis
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatology (Liver Conditions)
- Liver Cancer
- Liver Transplant
- Polycystic Liver Disease
Professional Education
- Fellowship: Mayo Graduate School of Medicine (1998) MN
- Fellowship: Mayo Graduate School of Medicine (1997) MN
- Residency: University of Arkansas for Medical Sciences Medical Center (1994) AR
- Professional Education: University of Pennsylvania (1992) PA
- Residency: Seoul National University Hospital (1990)
- Internship: Seoul National University Hospital (1987)
- Medical Education: Seoul National University (1986)
- Board Certification: Transplant Hepatology, American Board of Internal Medicine (2008)
- Board Certification: Gastroenterology, American Board of Internal Medicine (1998)
- M.B.A., Wharton School, University of Pennsylvania, Health Care Administration (1992)
- M.Sc., Seoul National University, Clinical Research (1990)
- M.D., Seoul National University, Medicine (1986)
Administrative Appointments
- Chief, Division of Gastroenterology & Hepatology, Department of Medicine, Stanford Unversity (2013 - Present)
Publications
-
Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate
Allen, A. M., Kim, W. R., Therneau, T. M., Larson, J. J., Heimbach, J. K., & Rule, A. D. (2014). Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate. JOURNAL OF HEPATOLOGY, 61(2), 286-292. -
Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study
Kim, B. H., Park, J.-W., Nam, B.- ho, Kwak, H. W., & Kim, W. R. (2014). Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study. LIVER INTERNATIONAL, 34(7), E317-E323. -
Effect of the Pretransplant Serum Sodium Concentration on Outcomes Following Liver Transplantation
Leise, M. D., Yun, B. C., Larson, J. J., Benson, J. T., Yang, J. D., & Kim, W. R. (2014). Effect of the Pretransplant Serum Sodium Concentration on Outcomes Following Liver Transplantation. LIVER TRANSPLANTATION, 20(6), 687-697. -
Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
Al-Bawardy, B., Kim, W. R., Poterucha, J. J., Gross, J. B., Charlton, M. R., & Therneau, T. M. (2014). Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C. MAYO CLINIC PROCEEDINGS, 89(5), 595-601.
-
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.
Zhang, X., Harmsen, W. S., Mettler, T. A., Kim, W. R., Roberts, R. O., & Chaiteerakij, R. (2014). Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology (Baltimore, Md.).
-
Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease
Allen, A. M., Kim, W. R., Larson, J., & Loftus, E. V. (2013). Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(12), 1655-U321.
-
Risk Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis: The ADRESS-HCC Risk Model
Flemming, J. A., Vittinghoff, E., Kim, W. R., & Terrault, N. (2013). Risk Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis: The ADRESS-HCC Risk Model. HEPATOLOGY, 58, 1219A-1220A.
-
Impact of the center on graft failure after liver transplantation
Asrani, S. K., Kim, W. R., Edwards, E. B., Larson, J. J., Thabut, G., & Heimbach, J. (2013). Impact of the center on graft failure after liver transplantation. LIVER TRANSPLANTATION, 19(9), 957-964.
-
Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J., & Ehman, R. L. (2013). Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography. RADIOLOGY, 268(2), 411-419.
-
Underestimation of Liver-Related Mortality in the United States
Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R. (2013). Underestimation of Liver-Related Mortality in the United States. GASTROENTEROLOGY, 145(2), 375-?.
-
Hepatitis B Screening and Vaccination Practices in Asian American Primary Care
Chu, D., Yang, J. D., Lok, A. S., Tram Tran, T., Martins, E. B., & Kim, W. R. (2013). Hepatitis B Screening and Vaccination Practices in Asian American Primary Care. GUT AND LIVER, 7(4), 450-457.
-
Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation
Murad, S. D., Heimbach, J. K., Gores, G. J., Rosen, C. B., Benson, J. T., & Kim, W. R. (2013). Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. LIVER TRANSPLANTATION, 19(5), 521-528.
-
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
Kim, D., Kim, W. R., Kim, H. J., & Therneau, T. M. (2013). Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. HEPATOLOGY, 57(4), 1357-1365.
-
Predicting clinical outcomes with elastography in primary biliary cirrhosis: one step closer?
Singh, S., Kim, W. R., & Talwalkar, J. A. (2013). Predicting clinical outcomes with elastography in primary biliary cirrhosis: one step closer?. Gastroenterology, 144(4), 851-852.
-
Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., & Roberts, L. R. (2013). Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk. HEPATOLOGY, 57(2), 648-655.
-
Kidney, Pancreas and Liver Allocation and Distribution in the United States
Smith, J. M., Biggins, S. W., Haselby, D. G., Kim, W. R., Wedd, J., & Israni, A. K. (2012). Kidney, Pancreas and Liver Allocation and Distribution in the United States. AMERICAN JOURNAL OF TRANSPLANTATION, 12(12), 3191-3212.
-
Simultaneous Liver-Kidney Transplantation Summit: Current State and Future Directions
Nadim, M. K., Sung, R. S., Davis, C. L., Andreoni, K. A., Biggins, S. W., & Genyk, Y. S. (2012). Simultaneous Liver-Kidney Transplantation Summit: Current State and Future Directions. AMERICAN JOURNAL OF TRANSPLANTATION, 12(11), 2901-2908.
-
Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma
Murad, S. D., Kim, W. R., Therneau, T., Gores, G. J., Rosen, C. B., & Heimbach, J. K. (2012). Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. HEPATOLOGY, 56(3), 972-981.
-
Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008
Yang, J. D., Kim, B., Sanderson, S. O., St Sauver, J., Yawn, B. P., & Kim, W. R. (2012). Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008. AMERICAN JOURNAL OF GASTROENTEROLOGY, 107(8), 1256-1262.
-
Model to estimate survival in ambulatory patients with hepatocellular carcinoma
Yang, J. D., Kim, W. R., Park, K. W., Chaiteerakij, R., Kim, B., & Park, J.-W. (2012). Model to estimate survival in ambulatory patients with hepatocellular carcinoma. HEPATOLOGY, 56(2), 614-621.
-
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., & Kim, W. R. (2012). Nonalcoholic fatty liver disease is associated with coronary artery calcification. HEPATOLOGY, 56(2), 605-613.
-
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., & Heimbach, J. K. (2012). Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology, 143(1), 88-98 e3.
-
Hospitalization for Underage Drinkers in the United States
Kim, J. Y., Asrani, S. K., Shah, N. D., Kim, W. R., & Schneekloth, T. D. (2012). Hospitalization for Underage Drinkers in the United States. JOURNAL OF ADOLESCENT HEALTH, 50(6), 648-650.
-
Development of organ-specific donor risk indices
Akkina, S. K., Asrani, S. K., Peng, Y., Stock, P., Kim, W. R., & Israni, A. K. (2012). Development of organ-specific donor risk indices. LIVER TRANSPLANTATION, 18(4), 395-404.
-
Nonalcoholic fatty liver disease associated with coronary artery calcification
Kim, D., Choi, Sy., Park, Eh., Lee, W., Kang, Jh., & Kim, Wr. (2012). Nonalcoholic fatty liver disease associated with coronary artery calcification. Hepatology, 56(2).
-
Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis
Yang, J. D., & Kim, W. R. (2012). Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(1), 16-21.
-
Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance
Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Chaiteerakij, R., Enders, F. T., & Roberts, L. R. (2011). Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 9(7), 617-U141.
-
A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation
Leise, M. D., Kim, W. R., Kremers, W. K., Larson, J. J., Benson, J. T., & Therneau, T. M. (2011). A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation. GASTROENTEROLOGY, 140(7), 1952-1960.
-
Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma
Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R., & Lindor, K. D. (2011). Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 9(5), 434-U1433.
-
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., & Roberts, L. R. (2011). Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 9(1), 64-70.
-
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities.
DiBonaventura, M. D., Wagner, J.-S., Yuan, Y., L'Italien, G., Langley, P., & Ray Kim, W. (2011). The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. Journal of medical economics, 14(2), 253-261.
-
Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies
Yang, J. D., Kim, E., Pedersen, R. A., Kim, W. R., Pungpapong, S., & Roberts, L. R. (2010). Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies. GUT AND LIVER, 4(4), 537-542.
-
Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant
Bambha, K., Kim, W. R., Rosen, C. B., Pedersen, R. A., Rys, C., & Therneau, T. M. (2010). Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant. MAYO CLINIC PROCEEDINGS, 85(9), 814-820.
-
Humanistic and economic impacts of hepatitis C infection in the United States.
DiBonaventura, M. D., Wagner, J.-S., Yuan, Y., L'Italien, G., Langley, P., & Ray Kim, W. (2010). Humanistic and economic impacts of hepatitis C infection in the United States. Journal of medical economics, 13(4), 709-718.
